CTMX Financials
Cytomx Therapeutics Inc - Financial statements & key metrics
Stock Price
$4.45
Market Cap
$996.58M
EPS
$-0.15
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$138.10M
Gross Profit
-
Operating Income
-
Net Income
$31.87M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$120.53M
Total Liabilities
$120.99M
Shareholders Equity
-
Cash & Equivalents
$38.05M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-86.23M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
100.0%
Operating Margin
-37.9%
Net Margin
-0.2%
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CTMX revenue?
CTMX's most recent quarterly revenue was $138.10M. Annual revenue can be calculated by summing the four most recent quarters.
Is CTMX profitable?
CTMX reported a profit of $31.87M in the most recent quarter. The net profit margin is -0.2%.
What is CTMX market cap?
CTMX has a market capitalization of $996.58M, making it a small-cap stock.
Does CTMX have debt?
View CTMX's balance sheet for debt information.
What is CTMX cash flow?
Cash flow data is available in the full financial statements.